Riluzole

Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients With ALS

Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)

MIROCALS: Modifying Immune Response and OutComes in ALS

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy.

Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia

Riluzole in Patients With Spinocerebellar Ataxia Type 7

Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS

The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)

Riluzole in the Treatment of Spasticity in the Traumatic Chronic Spinal Cord Injury Condition

Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Riluzole in Mild Alzheimer's Disease

Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL)